Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph phase_1
3
60%
Ph early_phase_1
2
40%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Other(1)

Detailed Status

Not yet recruiting3
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (40.0%)
Phase 13 (60.0%)

Trials by Status

unknown120%
not_yet_recruiting360%
recruiting120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5